Drugs / SAR-407899 FREE BASE
SAR-407899 FREE BASE
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03236311 | Oct 2017 → Jul 2018 | coronary microvascular disorder | Sanofi | Terminated | No outcome recorded |
| Phase 2 | NCT00914277 | May → Sep 2009 | erectile dysfunction | Sanofi | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR-407899 FREE BASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1667969 ↗ |
| Known as | Sar-407899 hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL1667969 ↗ |
| Known as | SAR407899 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00914277 ↗ |
| Modality | Small molecule | — CHEMBL1667969 ↗ |
| Route | Oral | “Route of administration: Oral” NCT03236311 ↗ |